Targeted activation of ErbB4 receptor ameliorates neuronal deficits and neuroinflammation in a food-borne polystyrene

Chong Liu1, Yan Zhao2, Wei Zhang1,3

  • 1MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Department of Cell Biology, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.

PubMed

Insights

Targeted activation of the epidermal growth factor receptor 4 (ErbB4) using E4A reduced cognitive deficits in mice exposed to polystyrene microplastics (PS-MPs). This approach also decreased neuroinflammation and neuronal damage, offering potential therapeutic strategies.

Area of Science:

  • Neuroscience
  • Toxicology
  • Pharmacology

Background:

  • Polystyrene microplastics (PS-MPs) impact the nervous system.
  • Epidermal growth factor receptor 4 (ErbB4) activation is key in neuronal injury and regeneration.

Purpose of the Study:

  • Investigate if targeted ErbB4 activation can mitigate PS-MPs-induced neuronal injury.
  • Evaluate the therapeutic potential of E4A, an ErbB4 agonist.

Main Methods:

  • Administered E4A to mice exposed to PS-MPs.
  • Assessed cognitive function, hippocampal neuronal health, and molecular markers.
  • Conducted in vitro experiments on hippocampal neurons and microglia.

Main Results:

  • E4A significantly improved cognitive behavior in PS-MPs-exposed mice.
  • E4A upregulated DOCK3 and SIRT3, mitigating mitochondrial and synaptic dysfunction.
  • E4A reduced neuroinflammation by inhibiting the TLR4-NF-κB-NLRP3 pathway.
  • E4A partially alleviated PS-MPs-induced neuronal injury and microglial inflammation in vitro.

Conclusions:

  • Targeted ErbB4 activation with E4A shows promise in mitigating PS-MPs-induced neurotoxicity.
  • This strategy may offer a therapeutic approach for cognitive dysfunction and neuroinflammation caused by microplastic exposure.

Related Concept Videos